VYGR Stock Summary and Trading Ideas (Voyager Therapeutics | NASDAQ:VYGR)

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

What symbol and exchange does Voyager Therapeutics shares trade?

Voyager Therapeutics trades on the NASDAQ stock market under the symbol VYGR.

What is Voyager Therapeutics stock price doing today?

As of July 6, 2026, VYGR stock price declined to $3.62 with 508,706 million shares trading.

What is Voyager Therapeutics's Beta?

VYGR has a beta of 1.15, meaning it tends to be more sensitive to market movements. VYGR has a correlation of 0.06 to the broad based SPY ETF.

How much is Voyager Therapeutics worth?

VYGR has a market cap of $218.71 million. This is considered a Small Cap stock.

How much money does Voyager Therapeutics make?

Last quarter Voyager Therapeutics reported $3 million in Revenue and -$.47 earnings per share. This fell short of revenue expectation by $-6 million and exceeded earnings estimates by $.07.

What is the highest and lowest price Voyager Therapeutics traded in the last 3 year period?

In the last 3 years, VYGR traded as high as $11.72 and as low as $2.65.

What are the top ETFs holding Voyager Therapeutics?

The top ETF exchange traded funds that VYGR belongs to (by Net Assets): VTI, IWM, VXF, IWN, IBB.

Is Voyager Therapeutics (VYGR) a good investment?

VYGR has underperformed the market in the last year with a price return of +13.1% while the SPY ETF gained +22.3%. VYGR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -8.6% and -2.7%, respectively, while the SPY returned +14.8% and +0.6%, respectively.

What are the support and resistance levels for Voyager Therapeutics (VYGR)?

VYGR support price is $3.64 and resistance is $3.92 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VYGR shares will trade within this expected range on the day.